Affiliated with a Castle Connolly Top Hospital
Who is Dr. Mitchell, Hematologist in Stanford, CA?
Dr. Beverly Mitchell, MD is a Hematologist, who primarily practices in Stanford, CA with 1 additional practice location. She is board certified by the American Board of Internal Medicine. Dr. Mitchell completed her residency at University of Washington. Dr. Mitchell is fluent in English, and is currently seeing new patients. Dr. Mitchell’s practice accepts Aetna, Cigna, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Mitchell’s office at (650) 498-5710.
What are Areas of Expertise for Dr. Mitchell?
Dr. Beverly Mitchell, MD is a highly-rated, board-certified Hematologist known for expertly diagnosing, treating, and managing a wide array of related conditions or procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Mitchell empowers patients to confidently navigate their health journey, specializing in Hematologic Malignancies, Leukemia & Lymphoma, or comprehensive wellness support. Serving the Stanford/CA community, Dr. Mitchell is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Mitchell go to medical school and complete their residency?
Fellowship: University of Michigan Hospital
Residency: University of Washington
Is Dr. Mitchell board certified in Hematologist?
Yes, Dr. Beverly Mitchell, MD is board certified by the American Board of Internal Medicine since 1978, American Board of Internal Medicine since 1973
What languages does Dr. Mitchell speak?
Dr. Mitchell and their clinical team can communicate with patients in the following languages:
English
Which conditions does Dr. Mitchell treat as a Hematologist?
As a Hematologist, conditions treated by a Dr. Beverly Mitchell may include:
Please contact Dr. Mitchell's office for more information or to schedule a consultation.
Which procedures does Dr. Mitchell perform as a Hematologist?
As a Hematologist, procedures performed by a Dr. Beverly Mitchell may include:
- 3D Conformal Radiotherapy
- Adaptive Radiation Therapy (ART)
- Adrenalectomy
- Blood Thinning Therapy / Anticoagulation
- Blood Transfusion Consultation
- Blood Transfusion Follow Up
- Bone Excision
- Bone Grafting
For detailed information, please contact Dr. Mitchell's office.
Does Dr. Mitchell accept my insurance?
Dr. Mitchell accepts most major insurance plans. Important: Please call our office at (650) 498-5710 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Mitchell accept in Stanford, CA?
Dr. Mitchell in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Aetna
Blue Cross Blue Shield
Blue Cross Blue Shield of Illinois
Blue Cross Blue Shield of Michigan
Capital Blue Cross
Cigna
Elevance Health Inc. (formerly Anthem)
Harvard Pilgrim
Oscar
Oxford Health Plans
View All Insurances
Where is Dr. Mitchell's office located?
Recognitions
Publications
Reduced rR expression and increased rD promoter methylation in CD34
BLOOD, 2012
Reactive Oxygen Species Regulate Nucleostemin Oligomerization and Protein Degradation
JOURL OF BIOLOGICAL CHEMISTRY, 2011
Determints of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H
LEUKEMIA RESEARCH, 2008
Guanine nucleotide depletion inhibits pre-ribosomal R synthesis and causes nucleolar proteins
Leuk Res, 2008
Phase I study of 506U78 administered on a consecutive 5-day schedule in children
JOURL OF CLINICAL ONCOLOGY, 2005
ACCO: ASCO core curriculum outline
JOURL OF CLINICAL ONCOLOGY, 2005
Effects of the IMP-dehydrogese inhibitor, Tiazofurin
LEUKEMIA RESEARCH, 2004
Role of human Pso4 in mammalian D repair and association with termil deoxynucleotidyl transferase
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2003
Sequential azacitidine plus lelidomide combition
Haematologica, 2013
Age and Genetics: How Do Prognostic Factors at Diagnosis Explain Disparities in Acute Myeloid
American jourl of clinical oncology
Understanding disparities in leukemia: a tiol study
CANCER CAUSES & CONTROL, 2012
Safety, efficacy and biological predictors of response to sequential azacitidine and lelidomide for
LEUKEMIA, 2012
Impact of TET2 mutations on mR expression
HEMATOLOGICAL ONCOLOGY, 2011
Guanine nucleotide depletion mediates translocation of nucleolar proteins
Nucleosides, nucleotides & nucleic acids, 2008
Tescin C interacts with ecto-5'-nucleotidase
Biochem Biophys Acta, 2008
Regulation of the interaction of inosine monophosphate dehydrogese with mycophenolic acid by GTP
JOURL OF BIOLOGICAL CHEMISTRY, 2006
Regulation of equilibrative nucleoside uptake by protein kise inhibitors
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2004
Targeted disruption of the inosine 5 '-monophosphate dehydrogese type I gene in mice
MOLECULAR AND CELLULAR BIOLOGY, 2003
The proteasome - An emerging therapeutic target in cancer
NEW ENGLAND JOURL OF MEDICINE, 2003
Inhibition of nucleoside transport by protein kise inhibitors
JOURL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003
Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic maligncies
JOURL OF CLINICAL ONCOLOGY, 2002
Clinical course of thrombocytopenia
AMERICAN JOURL OF HEMATOLOGY, 2002
Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received
JOURL OF CLINICAL ONCOLOGY, 2002
Inhibition of nucleoside transport by p38 MAPK inhibitors
JOURL OF BIOLOGICAL CHEMISTRY, 2002
Cyclosporin A and FK506 decrease adenosine kise activity and adenosine uptake in T-lymphocytes
JOURL OF LABORATORY AND CLINICAL MEDICINE, 2002
Association of D polymerase mu (pol mu) with Ku and ligase IV
MOLECULAR AND CELLULAR BIOLOGY, 2002
Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kise
CANCER RESEARCH, 2002
Tumor uptake and elimition of 2 '
CLINICAL CANCER RESEARCH, 2001
Human cytosolic 5 '-nucleotidase I - Characterization and role in nucleoside alog resistance
JOURL OF BIOLOGICAL CHEMISTRY, 2001
Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II gene
JOURL OF CLINICAL INVESTIGATION, 2000
Association of termil deoxynucleotidyl transferase with Ku
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 1999
Tissue-specific regulation of the ecto
JOURL OF BIOLOGICAL CHEMISTRY, 1999
Nucleotide pool imbalance
JOURL OF CLINICAL INVESTIGATION, 1999
ATP and phosphate reciprocally affect subunit association of human recombint High Km 5 '
EUROPEAN JOURL OF BIOCHEMISTRY, 1999
Compound GW506U78 in refractory hematologic maligncies
JOURL OF CLINICAL ONCOLOGY, 1998
Inosine-5 '-monophosphate dehydrogese
PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 61, 1998
Regulation of inosine-5'
JOURL OF BIOLOGICAL CHEMISTRY, 1997
Adenosine metabolism during phorbol myristate acetate-mediated induction of HL
JOURL OF IMMUNOLOGY, 1997
Regulation of the human inosine monophosphate dehydrogese type I gene
JOURL OF BIOLOGICAL CHEMISTRY, 1997
Retroviral transfer of deoxycytidine kise into tumor cell lines enhances nucleoside toxicity
CANCER RESEARCH, 1996
Viral vector transduction of the human deoxycytidine kise cD sensitizes glioma cells to the
TURE MEDICINE, 1996
Cloning of human adenosine kise cD: Sequence similarity to microbial ribokises and fructokises
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 1996
Inosine monophosphate dehydrogese expression
ADVANCES IN ENZYME REGULATION, VOL 36, 1996
Transcriptiol regulationof the IMPDH type I and II genes
Adv Enzyme Regul, 1996
RECOMBINT HUMAN INOSINE MONOPHOSPHATE DEHYDROGESE TYPE-I AND TYPE
BIOCHEMICAL PHARMACOLOGY, 1995
GTP DEPLETION INDUCED BY IMP DEHYDROGESE INHIBITORS BLOCKS R-PRIMED D-SYNTHESIS
MOLECULAR PHARMACOLOGY, 1995
CHARACTERIZATION OF THE DEOXYCYTIDINE KISE PROMOTER IN HUMAN LYMPHOBLAST CELL-LINES
JOURL OF CLINICAL INVESTIGATION, 1995
CHARACTERIZATION OF THE HUMAN INOSINE-5'-MONOPHOSPHATE DEHYDROGESE TYPE-II GENES
JOURL OF BIOLOGICAL CHEMISTRY, 1995
ASSIGNMENT OF THE HUMAN TYPE-I IMP DEHYDROGESE GENE (IMPDH1) TO CHROMOSOME 7Q31.3-Q32
GENOMICS, 1994
HEREDITARY OVEREXPRESSION OF ADENOSINE-DEAMISE IN ERYTHROCYTES
BLOOD, 1994
STRUCTURAL-ALYSIS OF THE DEOXYCYTIDINE KISE GENE IN PATIENTS WITH ACUTE MYELOID
LEUKEMIA, 1994
EFFECTS OF HUMAN T-LYMPHOCYTE ACTIVATION ON INOSINE MONOPHOSPHATE DEHYDROGESE EXPRESSION
JOURL OF IMMUNOLOGY, 1994
HEREDITARY OVEREXPRESSION OF ADENOSINE-DEAMISE IN ERYTHROCYTES - EVIDENCE FOR A CIS-ACTING MUTATION
AMERICAN JOURL OF HUMAN GENETICS, 1993
TYPE-I INOSINE MONOPHOSPHATE DEHYDROGESE - EVIDENCE FOR A SINGLE FUNCTIOL GENE IN MAMMALIAN-SPECIES
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993
GENOMIC STRUCTURE AND CHROMOSOMAL LOCALIZATION OF THE HUMAN DEOXYCYTIDINE KISE GENE
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 1993
REGULATION OF HUMAN DEOXYCYTIDINE KISE EXPRESSION
Mitchell, B. S., Song, J. J., Johnson, E. E., Chen, E., DAYTON, J. S., 1993
IMP DEHYDROGESE INHIBITORS AS IMMUNOMODULATORS
Mitchell, B. S., DAYTON, J. S., Turka, L. A., Thompson, C. B., 1993
GUANINE RIBONUCLEOTIDE DEPLETION INHIBITS T-CELL ACTIVATION
JOURL OF CLINICAL INVESTIGATION, 1991
CLONING AND EXPRESSION OF HUMAN DEOXYCYTIDINE KISE CD
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 1991
Development of an in vitro model system to study the physiologic effects
Altertive Methods in Toxicology, 1991
ERYTHROCYTE ADENOSINE-DEAMISE OVERPRODUCTION IN HEREDITARY HEMOLYTIC-ANEMIA
BLOOD, 1989
KINETIC-PROPERTIES AND INHIBITION OF HUMAN LYMPHOBLAST-T DEOXYCYTIDINE KISE
JOURL OF BIOLOGICAL CHEMISTRY, 1989
HUMAN T-LYMPHOBLAST DEOXYCYTIDINE KISE - PURIFICATION AND PROPERTIES
BIOCHEMISTRY, 1989
Properties of highly purified human T lymphoblast (MOLT-4) deoxycytidine kise.
Advances in experimental medicine and biology, 1989
Identification of an Apa I polymorphism within the human adenosine deamise gene
Nucl Acids Res, 1989
Erythrocyte-specific overproduction of adenosine deamise: molecular genetic studies.
Progress in clinical and biological research, 1989
Autosomal domint hemolytic anemia and adenosine deamise overproduction.
Advances in experimental medicine and biology, 1989
GENETIC EXPRESSION OF ADENOSINE-DEAMISE IN HUMAN LYMPHOID MALIGNCIES
BLOOD, 1987
TRANSCRIPTIOL REGULATION OF THE C-MYC PROTOONCOGENE BY 1
JOURL OF BIOLOGICAL CHEMISTRY, 1987
ELEVATED ADENOSINE-DEAMISE ACTIVITY AND HEREDITARY HEMOLYTIC
JOURL OF CLINICAL INVESTIGATION, 1987
Molecular basis for elevated adenosine deamise activity in a kindred with hemolytic anemia
J Clin Invest, 1987
Z-NUCLEOTIDE ACCUMULATION IN ERYTHROCYTES FROM LESCH-NYHAN PATIENTS
JOURL OF CLINICAL INVESTIGATION, 1985
BIOCHEMICAL CONSEQUENCES OF ADENOSINE-DEAMISE INHIBITION INVIVO
ANLS OF THE NEW YORK ACADEMY OF SCIENCES, 1985
DIFFERENTIAL METABOLISM OF DEOXYRIBONUCLEOSIDES BY LEUKEMIC T
BRITISH JOURL OF HAEMATOLOGY, 1985
2'-DEOXYGUANOSINE TOXICITY FOR B
JOURL OF CLINICAL INVESTIGATION, 1984
PURINE METABOLIZING ENZYMES AS PREDICTORS OF LYMPHOBLAST SENSITIVITY TO DEOXYADENOSINE
JOURL OF LABORATORY AND CLINICAL MEDICINE, 1984
ADENOSINE-DEAMISE DEFICIENCY WITH NORMAL IMMUNE FUNCTION - AN ACIDIC ENZYME MUTATION
JOURL OF CLINICAL INVESTIGATION, 1983
Deficiencies of adenosine deamise and purine nucleoside phosphorylase
Med Gr Rounds, 1982
INHIBITION OF ADENOSINE-DEAMISE ACTIVITY RESULTS IN CYTO-TOXICITY TO T-LYMPHOBLASTS INVIVO
BLOOD, 1980
PURINOGENIC IMMUNODEFICIENCY DISEASES - CLINICAL-FEATURES AND MOLECULAR MECHANISMS
ANLS OF INTERL MEDICINE, 1980
MULTIPLE-MYELOMA - CURRENT CONCEPTS IN DIAGNOSIS AND MAGEMENT
MEDICAL CLINICS OF NORTH AMERICA, 1980
ATP DEPLETION AS A CONSEQUENCE OF ADENOSINE-DEAMISE INHIBITION IN MAN
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 1980
Treatment of acute lymphoblastic leukemia with the adenosine deamise inhibitor 2'-deoxycoformycin.
Advances in experimental medicine and biology, 1979
BIOCHEMICAL BASIS FOR DIFFERENTIAL DEOXYADENOSINE TOXICITY TO LYMPHOBLAST-T AND LYMPHOBLAST
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 1979
PURINOGENIC IMMUNODEFICIENCY DISEASES
JOURL OF CLINICAL INVESTIGATION, 1979
PURINOGENIC IMMUNODEFICIENCY DISEASES - SELECTIVE TOXICITY OF DEOXYRIBONUCLEOSIDES FOR T-CELLS
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 1978
Granulocyte and erythroid colony forming cells from rat marrow
In Erythropoiesis, kao K, Fisher J, Pakaku F (Eds) University Park Pre
Reversal of UDP-galactose 4-epimerase deficiency of human leukocytes in culture
Proc t Acad Sci (USA), 1975
EPIDEMIOLOGICAL ASPECTS OF NEOPLASTIC DISORDERS IN ISRAELI MIGRANT POPULATION .V. LYMPHOMAS
JOURL OF THE TIOL CANCER INSTITUTE, 1969
SEX CHROMATIN DETERMITIONS IN SELECTED CASES OF DEVELOPMENTAL SEX ABNORMALITIES
ACTA CYTOLOGICA, 1963
Reduced rRNA expression and increased rDNA promoter methylation in CD34
BLOOD, 2012
Effect of nucleophosmin1 haploinsufficiency on hematopoietic stem cells
LEUKEMIA, 2012
Cyclopentenyl Cytosine Induces Senescence
MOLECULAR PHARMACOLOGY, 2011
Reactive Oxygen Species Regulate Nucleostemin Oligomerization and Protein Degradation
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011
Depletion of Guanine Nucleotides Leads to the Mdm2
CANCER RESEARCH, 2009
Determinants of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H
LEUKEMIA RESEARCH, 2008
Guanine nucleotide depletion inhibits pre-ribosomal RNA synthesis and causes nucleolar proteins
Leuk Res, 2008
The 5 '-nucleotidases as regulators of nucleotide and drug metabolism
PHARMACOLOGY & THERAPEUTICS, 2005
Phase I study of 506U78 administered on a consecutive 5-day schedule in children
JOURNAL OF CLINICAL ONCOLOGY, 2005
Synergy between imatinib
BLOOD, 2005
Phase 1 trial of the proteasome inhibitor bortezomib
BLOOD, 2005
ACCO: ASCO core curriculum outline
JOURNAL OF CLINICAL ONCOLOGY, 2005
Effects of the IMP-dehydrogenase inhibitor, Tiazofurin
LEUKEMIA RESEARCH, 2004
Role of estrogen receptor in the regulation of ecto-5 '-nucleotidase and adenosine in breast cancer
CLINICAL CANCER RESEARCH, 2004
Role of human Pso4 in mammalian DNA repair
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2003
Role of cysteine 288 in nucleophosmin cytoplasmic mutations
LEUKEMIA, 2013
Sequential azacitidine plus lenalidomide combination
Haematologica, 2013
Age and Genetics: How Do Prognostic Factors at Diagnosis Explain Disparities in Acute Myeloid
American journal of clinical oncology
Understanding disparities in leukemia: a national study
CANCER CAUSES & CONTROL, 2012
Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide
LEUKEMIA, 2012
Synthesis of 2 '-Deoxy-2 '-[F-18]Fluoro-9-beta-D-Arabinofuranosylguanine
MOLECULAR IMAGING AND BIOLOGY, 2011
Impact of TET2 mutations on mRNA expression
HEMATOLOGICAL ONCOLOGY, 2011
Guanine nucleotide depletion mediates translocation of nucleolar proteins
Nucleosides, nucleotides & nucleic acids, 2008
Tenascin C interacts with ecto-5'-nucleotidase
Biochem Biophys Acta, 2008
Nelarabine induces complete remissions in adults with relapsed or refractory T
BLOOD, 2007
Nelarabing induces complete remissions in adults with relapsed or refractory t
Blood, 2007
Effect of lysophosphatidic acid acyltransferase-beta inhibition in acute leukemia
LEUKEMIA RESEARCH, 2006
Regulation of the interaction of inosine monophosphate dehydrogenase with mycophenolic acid by GTP
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006
Effect of lysosphatidic acid acyltransferase-B inhibition in acute luekemia
Leu Res, 2006
Regulation of equilibrative nucleoside uptake by protein kinase inhibitors
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2004
On the molecular pathology of neurodegeneration in IMPDH1-based retinitis pigmentosa
HUMAN MOLECULAR GENETICS, 2004
Targeted disruption of the inosine 5 '-monophosphate dehydrogenase type I gene in mice
MOLECULAR AND CELLULAR BIOLOGY, 2003
The proteasome - An emerging therapeutic target in cancer
NEW ENGLAND JOURNAL OF MEDICINE, 2003
Induction of apoptosis in IL-3-dependent hematopoietic cell lines by guanine nucleotide depletion
BLOOD, 2003
Inhibition of nucleoside transport by protein kinase inhibitors
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003
Phase I trial of the proteasome inhibitor PS
JOURNAL OF CLINICAL ONCOLOGY, 2002
Clinical course of thrombocytopenia
AMERICAN JOURNAL OF HEMATOLOGY, 2002
Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received
JOURNAL OF CLINICAL ONCOLOGY, 2002
A77 1726 induces differentiation of human myeloid leukemia K562 cells by depletion
MOLECULAR PHARMACOLOGY, 2002
Inhibition of nucleoside transport by p38 MAPK inhibitors
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002
Cyclosporin A and FK506 decrease adenosine kinase activity and adenosine uptake in T-lymphocytes
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2002
Association of DNA polymerase mu (pol mu) with Ku and ligase IV
MOLECULAR AND CELLULAR BIOLOGY, 2002
Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase
CANCER RESEARCH, 2002
Tumor uptake and elimination of 2 '
CLINICAL CANCER RESEARCH, 2001
Human cytosolic 5 '-nucleotidase I - Characterization and role in nucleoside analog resistance
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001
Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II gene
JOURNAL OF CLINICAL INVESTIGATION, 2000
Association of terminal deoxynucleotidyl transferase with Ku
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 1999
Tissue-specific regulation of the ecto
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999
Nucleotide pool imbalance
JOURNAL OF CLINICAL INVESTIGATION, 1999
ATP and phosphate reciprocally affect subunit association of human recombinant High Km 5 '
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999
The use of the lectin Helix pomatia agglutinin
HISTOLOGY AND HISTOPATHOLOGY, 1999
Compound GW506U78 in refractory hematologic malignancies
JOURNAL OF CLINICAL ONCOLOGY, 1998
Lectin histochemistry of human leukaemic mast cells
ACTA HISTOCHEMICA, 1998
Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes
Blood, 1998
Inosine-5 '-monophosphate dehydrogenase
PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 61, 1998
Regulation of inosine-5'
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997
Cellular delivery of nucleoside diphosphates: A prodrug approach
PHARMACEUTICAL RESEARCH, 1997
Adenosine metabolism during phorbol myristate acetate-mediated induction of HL
JOURNAL OF IMMUNOLOGY, 1997
Regulation of the human inosine monophosphate dehydrogenase type I gene
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997
Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity
CANCER RESEARCH, 1996
Viral vector transduction of the human deoxycytidine kin
NATURE MEDICINE, 1996
Cloning of human adenosine kinase cDNA
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 1996
Inosine monophosphate dehydrogenase expression
ADVANCES IN ENZYME REGULATION, VOL 36, 1996
Transcriptional regulationof the IMPDH type I and II genes
Adv Enzyme Regul, 1996
A 73 year-old woman with anemia and thrombocytopenia
J Am Ger Soc, 1996
RECOMBINANT HUMAN INOSINE MONOPHOSPHATE DEHYDROGENASE TYPE-I AND TYPE
BIOCHEMICAL PHARMACOLOGY, 1995
GTP DEPLETION INDUCED BY IMP DEHYDROGENASE INHIBITORS BLOCKS RNA-PRIMED DNA-SYNTHESIS
MOLECULAR PHARMACOLOGY, 1995
CHARACTERIZATION OF THE DEOXYCYTIDINE KINASE PROMOTER IN HUMAN LYMPHOBLAST CELL-LINES
JOURNAL OF CLINICAL INVESTIGATION, 1995
CHARACTERIZATION OF THE HUMAN INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE TYPE-II GENES
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995
ASSIGNMENT OF THE HUMAN TYPE-I IMP DEHYDROGENASE GENE (IMPDH1) TO CHROMOSOME 7Q31.3-Q32
GENOMICS, 1994
HEREDITARY OVEREXPRESSION OF ADENOSINE-DEAMINASE IN ERYTHROCYTES
BLOOD, 1994
STRUCTURAL-ANALYSIS OF THE DEOXYCYTIDINE KINASE GENE IN PATIENTS WITH ACUTE MYELOID
LEUKEMIA, 1994
EFFECTS OF HUMAN T-LYMPHOCYTE ACTIVATION ON INOSINE MONOPHOSPHATE DEHYDROGENASE EXPRESSION
JOURNAL OF IMMUNOLOGY, 1994
Regulation of low Km (Ecto-) 5'-nucleotidase gene expression in leukemic cells
Spychala, J., Mitchell, B. S., 1994
HEREDITARY OVEREXPRESSION OF ADENOSINE-DEAMINASE IN ERYTHROCYTES
AMERICAN JOURNAL OF HUMAN GENETICS, 1993
TYPE-I INOSINE MONOPHOSPHATE DEHYDROGENASE
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993
GENOMIC STRUCTURE AND CHROMOSOMAL LOCALIZATION OF THE HUMAN DEOXYCYTIDINE KINASE GENE
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 1993
REGULATION OF HUMAN DEOXYCYTIDINE KINASE EXPRESSION
Mitchell, B. S., Song, J. J., Johnson, E. E., Chen, E., DAYTON, J. S., 1993
IMP DEHYDROGENASE INHIBITORS AS IMMUNOMODULATORS
Mitchell, B. S., DAYTON, J. S., Turka, L. A., Thompson, C. B., 1993
RESISTANCE TO 1-BETA
CANCER RESEARCH, 1992
COMPARISON OF THE EFFECTS OF MIZORIBINE WITH THOSE OF AZATHIOPRINE, 6-MERCAPTOPURINE
MOLECULAR PHARMACOLOGY, 1992
GUANINE RIBONUCLEOTIDE DEPLETION INHIBITS T-CELL ACTIVATION
JOURNAL OF CLINICAL INVESTIGATION, 1991
CLONING AND EXPRESSION OF HUMAN DEOXYCYTIDINE KINASE CDNA
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 1991
Guanine ribonucleotide depletion inhibits T cell activation.
Advances in experimental medicine and biology, 1991
Development of an in vitro model system to study the physiologic effects
Alternative Methods in Toxicology, 1991
CD11C (LEU-M5) EXPRESSION CHARACTERIZES A B-CELL CHRONIC LYMPHOPROLIFERATIVE DISORDER WITH FEATURES
BLOOD, 1990
MUTATIONS INDUCED AT THE HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE LOCUS OF HUMAN T
CANCER RESEARCH, 1990
DIFFERENTIAL METABOLISM OF 9-BETA-D-ARABINOFURANOSYLGUANINE IN HUMAN-LEUKEMIC CELLS
CANCER RESEARCH, 1989
ASSOCIATION OF A MATURE B-CELL LEUKEMIA WITH A 4P+ CHROMOSOMAL ABNORMALITY
LEUKEMIA, 1989
ERYTHROCYTE ADENOSINE-DEAMINASE OVERPRODUCTION IN HEREDITARY HEMOLYTIC-ANEMIA
BLOOD, 1989
KINETIC-PROPERTIES AND INHIBITION OF HUMAN LYMPHOBLAST-T DEOXYCYTIDINE KINASE
JOURNAL OF BIOLOGICAL CHEMISTRY, 1989
HUMAN T-LYMPHOBLAST DEOXYCYTIDINE KINASE - PURIFICATION AND PROPERTIES
BIOCHEMISTRY, 1989
Properties of highly purified human T lymphoblast (MOLT-4) deoxycytidine kinase.
Advances in experimental medicine and biology, 1989
Identification of an Apa I polymorphism within the human adenosine deaminase gene
Nucl Acids Res, 1989
Erythrocyte-specific overproduction of adenosine deaminase: molecular genetic studies.
Progress in clinical and biological research, 1989
Autosomal dominant hemolytic anemia and adenosine deaminase overproduction.
Advances in experimental medicine and biology, 1989
GENETIC EXPRESSION OF ADENOSINE-DEAMINASE IN HUMAN LYMPHOID MALIGNANCIES
BLOOD, 1987
TRANSCRIPTIONAL REGULATION OF THE C-MYC PROTOONCOGENE BY 1
JOURNAL OF BIOLOGICAL CHEMISTRY, 1987
ELEVATED ADENOSINE-DEAMINASE ACTIVITY AND HEREDITARY HEMOLYTIC
JOURNAL OF CLINICAL INVESTIGATION, 1987
Molecular basis for elevated adenosine deaminase activity in a kindred with hemolytic anemia
J Clin Invest, 1987
Characterization of arabinosylguanine resistance in a lymphoblastoid cell line.
Advances in experimental medicine and biology, 1986
Z-NUCLEOTIDE ACCUMULATION IN ERYTHROCYTES FROM LESCH-NYHAN PATIENTS
JOURNAL OF CLINICAL INVESTIGATION, 1985
BIOCHEMICAL CONSEQUENCES OF ADENOSINE-DEAMINASE INHIBITION INVIVO
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985
DIFFERENTIAL METABOLISM OF DEOXYRIBONUCLEOSIDES BY LEUKEMIC T
BRITISH JOURNAL OF HAEMATOLOGY, 1985
EFFECTS OF GUANINE RIBONUCLEOTIDE ACCUMULATION ON THE METABOLISM AND CELL-CYCLE OF HUMAN LYMPHOID
CANCER RESEARCH, 1985
Differential metabolism of deoxyribonucleosides by leukaemic T cells of immature
Br J Haemat, 1985
DIFFERENTIAL METABOLISM OF GUANINE NUCLEOSIDES BY HUMAN LYMPHOID-CELL LINES
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1985
METABOLISM AND SELECTIVE CYTO-TOXICITY OF 9-BETA-D-ARABINOFURANOSYLGUANINE IN HUMAN-LYMPHOBLASTS
CANCER RESEARCH, 1985
PLASMA-MEMBRANE 5'-NUCLEOTIDASE AND OTHER PURINE ENZYMES IN MURINE LYMPHOCYTES
ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1984
Erythrocyte ATP a dATP measurements predict toxicity following 2'-deoxycoformycin therapy
Cancer Treat Symp, 1984
2'-DEOXYGUANOSINE TOXICITY FOR B
JOURNAL OF CLINICAL INVESTIGATION, 1984
PURINE METABOLIZING ENZYMES AS PREDICTORS OF LYMPHOBLAST SENSITIVITY TO DEOXYADENOSINE
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1984
ALTERATIONS IN ERYTHROCYTE ADENINE-NUCLEOTIDE POOLS RESULTING FROM 2'-DEOXYCOFORMYCIN THERAPY
CANCER RESEARCH, 1983
DEOXYRIBONUCLEOSIDE TRIPHOSPHATE ACCUMULATION BY LEUKEMIC-CELLS
BLOOD, 1983
S-ADENOSYLHOMOCYSTEINE CATABOLISM AND BASIS FOR ACQUIRED
CANCER RESEARCH, 1983
ADENOSINE-DEAMINASE DEFICIENCY WITH NORMAL IMMUNE FUNCTION - AN ACIDIC ENZYME MUTATION
JOURNAL OF CLINICAL INVESTIGATION, 1983
Deficiencies of adenosine deaminase and purine nucleoside phosphorylase
Med Gr Rounds, 1982
Adult T-cell leukaemia-lymphoma with unusual phenotype
The Lancet (Letter), 1982
INHIBITION OF PURINE NUCLEOSIDE PHOSPHORYLASE BY 8-AMINOGUANOSINE
SCIENCE, 1981
INHIBITION OF ADENOSINE-DEAMINASE ACTIVITY RESULTS IN CYTO-TOXICITY TO T-LYMPHOBLASTS INVIVO
BLOOD, 1980
PURINOGENIC IMMUNODEFICIENCY DISEASES - CLINICAL-FEATURES AND MOLECULAR MECHANISMS
ANNALS OF INTERNAL MEDICINE, 1980
AN ASSAY OF DEOXYADENOSINE AND ADENOSINE IN HUMAN-PLASMA BY HPLC
BIOCHEMICAL MEDICINE, 1980
MULTIPLE-MYELOMA - CURRENT CONCEPTS IN DIAGNOSIS AND MANAGEMENT
MEDICAL CLINICS OF NORTH AMERICA, 1980
ATP DEPLETION AS A CONSEQUENCE OF ADENOSINE-DEAMINASE INHIBITION IN MAN
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 1980
Treatment of acute lymphoblastic leukemia with 2'-deoxycoformycin
Cancer treatment reports, 1979
Treatment of acute lymphoblastic leukemia with the adenosine deaminase inhibitor 2'
Advances in experimental medicine and biology, 1979
Molecular mechanism(s) of deoxyribonucleoside toxicity in T-lymphoblasts.
Advances in experimental medicine and biology, 1979
Possible role for 5'
Advances in experimental medicine and biology, 1979
BIOCHEMICAL BASIS FOR DIFFERENTIAL DEOXYADENOSINE TOXICITY TO LYMPHOBLAST-T AND LYMPHOBLAST
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 1979
PURINOGENIC IMMUNODEFICIENCY DISEASES
JOURNAL OF CLINICAL INVESTIGATION, 1979
PURINOGENIC IMMUNODEFICIENCY DISEASES - SELECTIVE TOXICITY OF DEOXYRIBONUCLEOSIDES FOR T-CELLS
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 1978
Uridine diphosphate galactose 4'-epimerase deficiency
Helv Paediat Acta, 1976
Granulocyte and erythroid colony forming cells from rat marrow
In Erythropoiesis, Nakao K, Fisher J, Pakaku F (Eds) University Park P
Reversal of UDP-galactose 4-epimerase deficiency of human leukocytes in culture
Proc Nat Acad Sci (USA), 1975
EPIDEMIOLOGICAL ASPECTS OF NEOPLASTIC DISORDERS IN ISRAELI MIGRANT POPULATION .V. LYMPHOMAS
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1969
The effect of phenylthiourea on melanogenesis of Fundulus Heteroclitus
Biological Bulletin, 1966
SEX CHROMATIN DETERMINATIONS IN SELECTED CASES OF DEVELOPMENTAL SEX ABNORMALITIES WITH AN
ACTA CYTOLOGICA, 1963
What is Dr. Mitchell's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Mitchell's National Provider Identifier (NPI) number is 1033169552.
What common questions do patients ask about Dr. Mitchell?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Mitchell
What is Dr. Beverly Mitchell's specialty?
Dr. Mitchell is a Hematologist near Stanford, CA. An internist with advanced training specializing in disorders of the blood, spleen, and lymphatic system. This specialist manages conditions such as anemia, clotting disorders, sickle cell disease, hemophilia, leukemia, and lymphoma. Contact Dr. Mitchell to book an appointment today.
Is this Dr. Beverly Mitchell affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Mitchell is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Hematologist?
Explore Hematologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Beverly Mitchell accepting new patients in Stanford, CA?
Yes, Dr. Beverly Mitchell is accepting new patients at this time.
Does Dr. Beverly Mitchell offer online booking?
Please contact Dr. Mitchell's office at (650) 498-5710 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Beverly Mitchell?
Please contact Dr. Mitchell's office at (650) 498-5710 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Beverly Mitchell have?
Dr. Beverly Mitchell is certified by the American Board of Internal Medicine.
Other Hematologist Near Stanford, CA
Medical Oncologist
Accepting patientsMedical Oncologist
Accepting patientsHematologist
Accepting patients